- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04358484
Implementation of Incredible Years for Autism and Language Delay Program in Spain (FS)
Protocol for a Randomized Pilot Study (FIRST STEPS): Implementation of the Incredible Years-ASLD® Program in Spanish Preschoolers With Autism and Premature Children With Communication or Socialization Difficulties
Children with autism spectrum disorders (ASD) usually present coexisting problems in emotion and behavior regulation, similarly as premature children with communication or socialization difficulties. Caring for children with neurodevelopmental difficulties is an important stressor for parents. Therefore, it is essential that families are offered evidence-based interventions at an early stage within the public health service. Group therapy is a cost-effective intervention that can help parents of children diagnosed with autism and those born prematurely. The Incredible Years - ASLD program is an example of this sort of therapy, consisting of a group intervention for parents of preschool children with a diagnosis of ASD or Language Delay. In Spain, group interventions for children with ASD and preterm children presenting with Language Delay are scarce in the public health service. The Incredible Years - ASLD program has not been translated into Spanish and it has not been previously implemented in our country.
The Incredible Years - ASLD group intervention will be carried out in three public Healthcare centers. It is intended to recruit 72 patients diagnosed with ASD or premature children with communication or socialization difficulties, which will be randomized to an Intervention Group or to Treatment as Usual (TAU) Group. The Intervention Group will receive fourteen sessions of the Incredible Years - ASLD program in addition to Treatment as Usual (TAU). In terms of clinical implications, this randomized pilot study could demonstrate the feasibility of implementing this intervention in the regular clinical settings within the Spanish public health service and could be a first step for future controlled studies that demonstrate its effectiveness.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder involving social communication disturbances and a restricted pattern of interests, present before age 3. Premature infants are at particular risk for neurodevelopmental disturbances, such as language delay, difficulties in social communication and ASD.
ASD is often associated with behavior difficulties, emotion regulation difficulties, psychiatric comorbidities and a dysfunctional response to sensory stimuli. Children with premature birth also present difficulties related to emotion and behavior regulation.
Due to these difficulties, caring for children with neurodevelopmental disorders can be very stressful for parents, which could in turn lead to lower effectiveness of interventions and greater mental health difficulties in parents.
Therefore, parenting interventions should not only address children's difficulties, these interventions should also aim to provide support for parents. Since no interventions have specifically addressed these two aspects in the treatment of neurodevelopmental disorders, several therapies have been adapted for this population. This is the case of the intervention at hand: Incredible Years - ASD and Language Delay (IY-ASLD).
In this intervention, in addition to learning strategies to promote the development of skills in children, parents receive support from other parents and from the therapists. The effectiveness of the Incredible Years program has been widely demonstrated in multiple randomized clinical trials, showing an improvement in terms of parental stress levels, depression and parental coping, as well as in children behavior difficulties. Incredible Years is also considered an evidence-based intervention according to the NICE guidelines.
The Incredible Years Program has been adapted for parents of children between ages 2 and 5 diagnosed with ASD, presenting ASD symptoms or language delay. A pilot study conducted in the UK has demonstrated high levels of acceptability, as well as a decrease in levels of parental stress associated with the care of their children. The results of a pilot randomized clinical trial in Wales have been recently published, supporting the feasibility of this intervention in the NHS and showing good levels of acceptability and fidelity to the program and compliance. The Incredible Years - ASLD Program has not been implemented in Spain and to the best of our knowledge it has not been used with parents of children of premature birth with communication and socialization difficulties.
This study aims to demonstrate the feasibility of reliably implementing the IY-ASLD parental program in different outpatient services of the Spanish public health service, as well as exploring its effectiveness in terms of reducing parental distress and improving children outcomes.
The IY - ASLD program will be implemented in three sites across Spain: Hospital Sant Joan de Déu Barcelona (HSJD), Hospital General Universitario Gregorio Marañón (HGUGM) and Hospital Materno Infantil (HMI) de Málaga. In the first site the program will be implemented with parents of premature children with communication and socialization impairment, and in the other two sites the program will be applied with parents of children diagnosed with ASD. The IY-ASLD program will consist of 22 weekly online group sessions for parents of children between 2-5 years of age. The sessions will be conducted by a therapist and a co-therapist, both trained in the program. A total of n = 72 parents (48 with ASD children and 24 with premature children) will be recruited and will be randomized to a control group (36 parents: 24 with ASD children and 12 with premature children) or group intervention (36 parents: 24 with ASD children and 12 with premature children).
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Esplugues de Llobregat, Spain
- Fundació Sant Joan de Deu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Inclusion criteria in HGUGM Madrid and HMI Málaga sites:
- Parents who have signed the Informed Consent.
- Parents of children diagnosed with ASD.
- Parents of children between the ages of 2 and 5 years, 11months.
- Fluency in Spanish.
Inclusion criteria in the HSJD Barcelona site:
- Parents who have signed the informed consent.
- Parents of children born with gestational age less than 37 weeks.
- Parents of children with communication or socialization difficulties (Vineland-III scores 1SD below the mean in any of the communication or socialization subdomains).
- Parents of children between the ages of 2 and 5 years, 11months.
- Fluency in Spanish
Exclusion Criteria:
- Attending another structured/manualized parenting program (focused on improving strategies for parents to help their children with behavioral and emotion regulation) at the time of the study.
- Parents of looked after children.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention Group
Participants attend The Incredible Years - ASLD parenting intervention and continue to receive usual care at their healthcare center
|
The IY - ASLD Program will consist of 22 weekly online group sessions for parents of children between 2-5 years of age with symptoms or a diagnosis of ASD or delayed language acquisition. The program will be conducted by a therapist and a co-therapist, trained in the model. Fidelity to the intervention will be assessed in accordance with the regulations of the program. All of the therapists and co-therapists will be trained in the intervention by accredited trainers. The three main therapists will be supervised by accredited supervisors of the IY Program, seeking accreditation in the intervention. As the intervention IY - ASLD has not been translated into Spanish, the English materials will be used with simultaneous translation into Spanish language. |
NO_INTERVENTION: Treatment As Usual (TAU) Group
Participants continue to receive usual care at their Healthcare Center
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Autism Program Parent Final Satisfaction Questionnaire
Time Frame: Administered to the intervention group at treatment completion (approximately 22 weeks after baseline).
|
Questionnaire for parents assessing their satisfaction with the IY-ASLD Program received.
|
Administered to the intervention group at treatment completion (approximately 22 weeks after baseline).
|
Register sheet of attendance
Time Frame: Administered to the intervention group weekly throughout treatment (22 weeks total)
|
Register of weekly attendance, aimed to determine levels of compliance with the intervention.
|
Administered to the intervention group weekly throughout treatment (22 weeks total)
|
Autism Program Parent Weekly Evaluation.
Time Frame: Administered to the intervention group weekly throughout treatment (22 weeks total)
|
Questionnaire assessing levels of satisfaction with each therapy session.This survey was specifically developed for the Incredible Years Program and can be found in the Incredible Years manual
|
Administered to the intervention group weekly throughout treatment (22 weeks total)
|
Incredible Years® Parent Strategies Questionnaire for Children with Autism (2-5 years)
Time Frame: Administered to the intervention group. Baseline (prior to programme initiation) and immediately after the intervention.
|
Questionnaire assessing type of parental strategies specifically aimed at helping children with ASD.
|
Administered to the intervention group. Baseline (prior to programme initiation) and immediately after the intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Parental Stress Index (PSI-SF) by Abidin.
Time Frame: Administered to both arms.First assessment before the groups randomization, pre-intervention assessment just before the programme initiation (due to the delay of the intervention because the COVID-19 pandemic), and immediately after the intervention.
|
Inventory assessing levels of parental stress regarding the care of their children.
|
Administered to both arms.First assessment before the groups randomization, pre-intervention assessment just before the programme initiation (due to the delay of the intervention because the COVID-19 pandemic), and immediately after the intervention.
|
Beck Depression Inventory (BDI)
Time Frame: Administered to both arms. First assessment before the groups randomization, pre-intervention assessment just before the programme initiation (due to the delay of the intervention because the COVID-19 pandemic), and immediately after the intervention.
|
Inventory of depressive symptoms for adults, reported by parents.
|
Administered to both arms. First assessment before the groups randomization, pre-intervention assessment just before the programme initiation (due to the delay of the intervention because the COVID-19 pandemic), and immediately after the intervention.
|
Autism Specify Five Minutes Speech Sample - ASFMSS
Time Frame: Administered to both arms. Baseline (prior to programme initiation) and immediately after the intervention.
|
It measures the construct Expressed emotion in parents of children with neurodevelopmental difficulties.
|
Administered to both arms. Baseline (prior to programme initiation) and immediately after the intervention.
|
Alabama Parenting Questionnaire Preschool revision (APQ-Pr).
Time Frame: Administered to both arms. Baseline (prior to programme initiation) and immediately after the intervention.
|
It assesses parenting practices, including positive, inconsistent and punitive parenting styles.
|
Administered to both arms. Baseline (prior to programme initiation) and immediately after the intervention.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Child Behavior Checklist (CBCL11/2-5), Achenbach.
Time Frame: Administered to both arms. Baseline (prior to programme initiation) and immediately after the intervention.
|
List of externalizing, internalizing and total problems.
Version for parents of children from 1.5 to 5 years.
|
Administered to both arms. Baseline (prior to programme initiation) and immediately after the intervention.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Laia Villalta, Medicine, Fundació Sant Joan de Deu
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Pregnancy Complications
- Obstetric Labor Complications
- Obstetric Labor, Premature
- Neurodevelopmental Disorders
- Child Development Disorders, Pervasive
- Language Disorders
- Communication Disorders
- Premature Birth
- Autistic Disorder
- Autism Spectrum Disorder
- Language Development Disorders
Other Study ID Numbers
- PIC-220-19
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on Incredible Years - ASD and Language Delay®
-
Haukeland University HospitalUniversity of Bergen; Norwegian University of Science and Technology; St. Olavs... and other collaboratorsRecruitingAutism Spectrum DisorderNorway
-
University of Maryland, BaltimoreTerminatedAutism Spectrum DisorderUnited States
-
Fundació Sant Joan de DéuHospital Universitari Vall d'Hebron Research Institute; Fundació La Marató... and other collaboratorsRecruitingParenting | Genetic Syndrome | Language Development | Autism or Autistic TraitsSpain
-
Children's Hospital Los AngelesNational Center for Advancing Translational Sciences (NCATS); AltaMed Health...SuspendedParenting | Child Behavior Problem | Child RearingUnited States
-
VIVE - The Danish Center for Social Science ResearchTRYG FoundationCompleted
-
Children's Hospital Los AngelesRobert Wood Johnson FoundationRecruiting
-
Johns Hopkins Bloomberg School of Public HealthNational Institute on Drug Abuse (NIDA)Completed
-
University of GlasgowNHS Fife; Chief Scientist Office of the Scottish GovernmentUnknownAttention Deficit Disorder With HyperactivityUnited Kingdom
-
Ferring PharmaceuticalsCompletedNeed for Bowel PreparationUnited States
-
National Institute on Aging (NIA)CompletedHyperglycemia | Hypertension | Obesity | HypercholesterolemiaUnited States